Skip to main content
. 2021 Sep 16;12:670425. doi: 10.3389/fendo.2021.670425

Table 2.

Afamin correlates with parameters of obesity, insulin resistance & physical activity.

Afamin adjusted for age
r p r p N
Age 0.366 <0.01 71
Obesity
Atherogenic index 0.589 <0.0001 0.419 <0.001 69
BMI 0.529 <0.0001 0.419 <0.001 71
Body fat % 0.526 <0.0001 0.428 <0.001 68
Fat cell size 0.519 <0.0001 0.392 <0.01 67
Waist circumference 0.513 <0.0001 0.409 <0.001 69
Fasting triglycerides 0.485 <0.0001 0.396 <0.001 70
Body weight 0.458 <0.0001 0.379 <0.01 71
hsCRP 0.444 <0.001 0.377 <0.01 67
Visceral AT 0.431 <0.001 0.251 <0.05 64
Subcutaneous AT 0.401 <0.01 0.305 <0.05 64
Fasting free fatty acids 0.312 <0.01 0.280 <0.05 70
Systolic blood pressure 0.206 >0.05 0.193 >0.05 58
Fasting cholesterol 0.214 >0.05 0.108 >0.05 70
LDL cholesterol 0.163 >0.05 0.053 >0.05 69
Liver parameters
Hepatic lipid content 0.721 <0.0001 0.595 <0.0001 60
GGT 0.656 <0.0001 0.567 <0.0001 70
Fatty liver index 0.655 <0.0001 0.536 <0.0001 68
ALT 0.528 <0.0001 0.496 <0.0001 70
AST 0.330 <0.01 0.320 <0.01 69
Diabetes
HOMA-IR 0.674 <0.0001 0.600 <0.0001 70
Fasting Insulin 0.646 <0.0001 0.616 <0.0001 70
M-value/Ins* -0.632 <0.0001 -0.560 <0.0001 70
Fasting C-peptide 0.614 <0.0001 0.516 <0.0001 69
Insulinemia AUC (oGTT) 0.593 <0.0001 0.599 <0.0001 61
Serum adiponectin -0.536 <0.0001 -0.478 <0.001 48
Fasting glycemia 0.473 <0.0001 0.291 <0.05 71
C-peptide AUC (oGTT) 0.417 <0.001 0.389 <0.01 61
Glycemia AUC (oGTT) 0.396 <0.01 0.273 <0.05 62
FFA-EHC** 0.346 <0.01 0.365 <0.01 69
Physical activity
Steps number/24h -0.268 <0.05 -0.327 <0.05 60
Sport index -0.267 <0.05 -0.229 >0.05 71
Leisure-time index -0.251 <0.05 -0.229 >0.05 71

ALT, alanine aminotransferase; AST, aspartate aminotransferase; AT, adipose tissue; AUC, area under the curve; BMI, body mass index; FFA-EHC, Free Fatty Acids measured in a steady state of the euglycemic hyperinsulinemic clamp/EHC; GGT, gamma-glutamyltransferase; HOMA-IR, HOMA insulin resistance index; hsCRP, high sensitivity C-reactive protein; M-value/Ins, insulin sensitivity normalized to steady state insulinemia, measured by EHC; Spearman correlation. *whole body insulin sensitivity, **adipose tissue-specific insulin sensitivity.